✦ LIBER ✦

Matrix metalloprotease-9 plasma levels in patients with liver diseases

✍ Scribed by A.M. Sonnante; R. Cozzolongo; O.G. Manghisi; M. Correale

Book ID: 119526006
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 147 KB
Volume: 32
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(00)80671-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased plasma levels of matrix metall

Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer’s disease

✍ Stefan Lorenzl; David S Albers; Norman Relkin; Terry Ngyuen; Sarah L Hilgenberg; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Matrix Metalloprotease–9 in Cerebrospina

Matrix Metalloprotease–9 in Cerebrospinal Fluid Correlates with Disease Activity in Lymphomatous Meningitis

✍ Wong, Eric T.; Lee, Diana; Tam, Angela; Gautam, Shiva; Wu, Julian K. 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 187 KB

Peripheral blood levels of matrix metall

Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes

✍ Hisashi Kai; Hisao Ikeda; Hideo Yasukawa; Mamiko Kai; Yukihiko Seki; Fumitaka Ku 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Plasma levels of pipecolic acid in patie

Plasma levels of pipecolic acid in patients with chronic liver disease

✍ Hironaka Kawasaki; Tatsuaki Hori; Masako Nakajima; Kenzo Takeshita 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 396 KB 👁 2 views

Plasma levels of pipecolic acid, which is a minor metabolite of lysine, were determined by high-performance liquid chromatography in 22 patients with chronic liver disease, composed of 6 patients with chronic active hepatitis, 11 with liver cirrhosis and 5 with hepatocellular carcinoma. The plasma l

CXCL5 plasma levels decrease in patients

CXCL5 plasma levels decrease in patients with chronic liver disease

✍ Frank Tacke; Henning W Zimmermann; Christian Trautwein; Bernd Schnabl 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 342 KB

1001-22 Urine and plasma matrix metallop

1001-22 Urine and plasma matrix metalloproteinase 9 and 2 levels in patients with coronary artery disease

✍ Patrick Fitzsimmons; Mark E Lawrence; Reza Forough; Brian Weylie; D Scott Gantt; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 114 KB